You are here

Access to medicines at risk as Brexit clock ticks

Many issues yet to be resolved before there can be free movement between UK and EU


TIME is running short for a Brexit agreement that will allow the free movement of medicines through the UK and the rest of the European Union.

A myriad of issues, including guidance on transferring product registration and drug testing in the region, are yet to be resolved,...

Market voices on: